Editorial
doi: 10.1016/j.jacc.2021.01.035.
Tracking Residual Risk: Time for a Change?
Affiliations
- PMID: 33736828
- DOI: 10.1016/j.jacc.2021.01.035
Item in Clipboard
Editorial
Tracking Residual Risk: Time for a Change?
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: LDL cholesterol; apolipoprotein B; mortality; myocardial infarction; non-HDL cholesterol; statin treatment.
Conflict of interest statement
Funding Support And Author Disclosures Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.J Am Coll Cardiol. 2021 Mar 23;77(11):1439-1450. doi: 10.1016/j.jacc.2021.01.027. J Am Coll Cardiol. 2021. PMID: 33736827
Similar articles
-
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16. J Clin Lipidol. 2015. PMID: 26228670
-
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.Lancet. 2010 Jul 31;376(9738):333-9. doi: 10.1016/S0140-6736(10)60713-1. Epub 2010 Jul 23. Lancet. 2010. PMID: 20655105 Clinical Trial.
-
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. J Manag Care Pharm. 2008. PMID: 19891279 Review.
-
[Diabetic dyslipidaemia and the atherosclerosis].Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441. Orv Hetil. 2016. PMID: 27133274 Review. Hungarian.
-
Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.Ann Clin Biochem. 2011 Nov;48(Pt 6):566-71. doi: 10.1258/acb.2011.010277. Epub 2011 Oct 17. Ann Clin Biochem. 2011. PMID: 22006975
Cited by
-
Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement.Cardiol Res Pract. 2022 Apr 27;2022:7537510. doi: 10.1155/2022/7537510. eCollection 2022. Cardiol Res Pract. 2022. PMID: 35529057 Free PMC article.
-
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease.Curr Atheroscler Rep. 2022 Mar;24(3):133-142. doi: 10.1007/s11883-022-00994-z. Epub 2022 Feb 17. Curr Atheroscler Rep. 2022. PMID: 35175548 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
